FIELD: biology; biotechnology; medicine.
SUBSTANCE: invention relates to a method for in vitro cultivation of natural killer (NK cells) in a nutrient medium with a combination of at least two cytokines: IL-2, IL-15, IL-18, IL-21 and K562-mb15-41BBL or K562-mb21-41BBL feeder cells. To implement this method, NK cells isolated from mononuclear cells (PBMC) of human peripheral blood are first added to the nutrient medium at a concentration of 1×105 to 1×106 per 1 ml of nutrient medium. After that, interleukins are added to the nutrient medium. Then feeder cells are added to the medium in ratios from 1:1 to 1:10. The entire process of culturing NK cells is 14–21 days, during which the replacement of the nutrient medium is carried out every 2–5 days from the beginning of cultivation. RPMI-1640 is used as a nutrient medium, in step (b) interleukins are added to the nutrient medium starting from day 0, in step (c) they start on day 5–8. Cultivation is carried out in a multi-gas incubator at 37°C in an atmosphere of 5% of CO2 or 5% of CO2 and 5-10% of O2.
EFFECT: claimed method allows to obtain cell preparations with a high content of NK cells, namely up to 50×107 cells, and allows to increase the functional activity of NK cells.
4 cl, 6 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EXPANSION OF HUMAN NK CELLS USING FEEDER CELLS | 2021 |
|
RU2781777C2 |
RECOMBINANT CELL LINE TMDK562-15 SHOWING THE ABILITY TO ACTIVATE AND PROLIFERATE HUMAN NK CELLS | 2022 |
|
RU2803178C1 |
METHOD OF PRODUCING CYTOTOXIC LYMPHOCYTES USING IFN-γ AND TNF-α FOR ADOPTIVE IMMUNOTHERAPY | 2023 |
|
RU2822876C2 |
METHOD FOR PRODUCTION OF NATURAL KILLER CELLS, AND COMPOSITION FOR CANCER TREATMENT | 2019 |
|
RU2780848C2 |
UNIVERSAL ANTIGEN PRESENTING CELLS AND THEIR USE | 2019 |
|
RU2809113C2 |
PARTICLES PM21 FOR IMPROVEMENT OF HOMING OF NK-CELLS IN BONE MARROW | 2018 |
|
RU2777993C2 |
METHOD OF CYTOGENETIC ACTIVATION OF HUMAN LYMPHOCYTES | 2015 |
|
RU2603079C2 |
EXPANSION OF LYMPHOCYTE WITH A CYTOKINE COMPOSITION FOR ACTIVE CELLULAR IMMUNOTHERAPY | 2015 |
|
RU2739770C2 |
CENTRAL MEMORY T-CELLS OF AGAINST THIRD PARTY, METHODS FOR THEIR PRODUCTION AND THEIR APPLICATION IN TRANSPLANTATION AND DISEASES TREATMENT | 2012 |
|
RU2636503C2 |
METHOD FOR ACTIVATION OF CYTOTOXIC LYMPHOCYTES | 2019 |
|
RU2751837C2 |
Authors
Dates
2023-04-24—Published
2021-12-28—Filed